Catalyst Wire Dossier Catalyst Wire Dossier

Requip XL (ropinirole extended-release)

ropinirole · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Requip XL (ropinirole extended-release), covering 2011-10-07 to 2011-10-07. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Evaluation of Ropinirole Prolonged Release/Extended Release (PR/XR) Tablet for Adjunctive Therapy to L-dopa in Subjects With Advanced Parkinson's Disease [Phase 3]

See pricing